Federal campaign to discourage antidepressant use could cause new problems

Department of Health and Human Services (HHS) has launched a campaign to reduce reliance on psychiatric medications, including antidepressants, framing their use as overprescribed. Critics—including medical journals like *JAMA*—warn the initiative risks stigmatizing treatment and harming patients who depend on these medications for managing conditions like depression and anxiety. Coverage highlights a divide between public health officials and medical professionals. *Psychology Today* and *Spectrum News* report that HHS’s messaging may undermine trust in evidence-based treatments, while *Yahoo* and *prismreports.org* cite expert concerns that stigma could deter those in need from seeking help.

The *Star Tribune* frames the debate as a clash between regulatory caution and patient care priorities. Watch for potential policy shifts in mental health treatment guidelines and reactions from pharmaceutical companies or advocacy groups. Legal challenges or legislative responses may emerge if the campaign is seen as overreaching or insufficiently evidence-based.

Patient organizations may also mobilize to counter perceived restrictions on access to care.